Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma

Deepak Rai, Shailaja Karanti, Inkyung Jung, Patricia L Dahia, Ricardo C Aguiar

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) attenuate gene expression by pairing to the 3′UTR of target transcripts inducing RNA cleavage or translational inhibition. Overexpression of microRNA-155 (miR-155), measured either at the primary (BIC gene) or mature transcript level, was recently described in diffuse large B-cell lymphomas (DLBCL). These studies have been limited in size, however, and have not attempted to link miR-155 expression to that of putative target genes. To start to address these issues, we examined a collection of 22 well-characterized DLBCL cell lines. The expression of miR-155 is heterogeneous in these cell lines and associates with NF-κB activity. We found that the expression of the primary miR-155 transcript reliably reflects that of the functional mature miR-155. Because many gene array platforms include probe sets for the primary miR-155 sequences, these findings allowed us to confidently examine large array-based expression datasets of primary DLBCLs in the context of miR-155 levels. Our investigation revealed that miR-155 expression segregates with specific molecular subgroups of DLBCL and it is highest in activated B-cell (ABC)-type lymphomas. These tumors are characterized by constitutive activation of NF-κB signals, which supports the data derived from our cell lines. More importantly, using supervised learning algorithms, we identified a robust gene signature driven by the differential expression of miR-155. These profiles contained several gene markers, including predicted targets, consistently downregulated in tumors expressing high levels of miR-155. Our data start to unveil the genome-wide effects of miR-155 expression in DLBCL and indicate the utility of this strategy in the identification and validation of miRNA target genes.

Original languageEnglish (US)
Pages (from-to)8-15
Number of pages8
JournalCancer Genetics and Cytogenetics
Volume181
Issue number1
DOIs
StatePublished - Feb 2008

Fingerprint

Lymphoma, Large B-Cell, Diffuse
MicroRNAs
Genes
imidazole mustard
Cell Line
RNA Cleavage
B-Cell Lymphoma
Neoplasms
Down-Regulation

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. / Rai, Deepak; Karanti, Shailaja; Jung, Inkyung; Dahia, Patricia L; Aguiar, Ricardo C.

In: Cancer Genetics and Cytogenetics, Vol. 181, No. 1, 02.2008, p. 8-15.

Research output: Contribution to journalArticle

@article{f47e7d01e02f4f02a9326c649c6da198,
title = "Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma",
abstract = "MicroRNAs (miRNAs) attenuate gene expression by pairing to the 3′UTR of target transcripts inducing RNA cleavage or translational inhibition. Overexpression of microRNA-155 (miR-155), measured either at the primary (BIC gene) or mature transcript level, was recently described in diffuse large B-cell lymphomas (DLBCL). These studies have been limited in size, however, and have not attempted to link miR-155 expression to that of putative target genes. To start to address these issues, we examined a collection of 22 well-characterized DLBCL cell lines. The expression of miR-155 is heterogeneous in these cell lines and associates with NF-κB activity. We found that the expression of the primary miR-155 transcript reliably reflects that of the functional mature miR-155. Because many gene array platforms include probe sets for the primary miR-155 sequences, these findings allowed us to confidently examine large array-based expression datasets of primary DLBCLs in the context of miR-155 levels. Our investigation revealed that miR-155 expression segregates with specific molecular subgroups of DLBCL and it is highest in activated B-cell (ABC)-type lymphomas. These tumors are characterized by constitutive activation of NF-κB signals, which supports the data derived from our cell lines. More importantly, using supervised learning algorithms, we identified a robust gene signature driven by the differential expression of miR-155. These profiles contained several gene markers, including predicted targets, consistently downregulated in tumors expressing high levels of miR-155. Our data start to unveil the genome-wide effects of miR-155 expression in DLBCL and indicate the utility of this strategy in the identification and validation of miRNA target genes.",
author = "Deepak Rai and Shailaja Karanti and Inkyung Jung and Dahia, {Patricia L} and Aguiar, {Ricardo C}",
year = "2008",
month = "2",
doi = "10.1016/j.cancergencyto.2007.10.008",
language = "English (US)",
volume = "181",
pages = "8--15",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma

AU - Rai, Deepak

AU - Karanti, Shailaja

AU - Jung, Inkyung

AU - Dahia, Patricia L

AU - Aguiar, Ricardo C

PY - 2008/2

Y1 - 2008/2

N2 - MicroRNAs (miRNAs) attenuate gene expression by pairing to the 3′UTR of target transcripts inducing RNA cleavage or translational inhibition. Overexpression of microRNA-155 (miR-155), measured either at the primary (BIC gene) or mature transcript level, was recently described in diffuse large B-cell lymphomas (DLBCL). These studies have been limited in size, however, and have not attempted to link miR-155 expression to that of putative target genes. To start to address these issues, we examined a collection of 22 well-characterized DLBCL cell lines. The expression of miR-155 is heterogeneous in these cell lines and associates with NF-κB activity. We found that the expression of the primary miR-155 transcript reliably reflects that of the functional mature miR-155. Because many gene array platforms include probe sets for the primary miR-155 sequences, these findings allowed us to confidently examine large array-based expression datasets of primary DLBCLs in the context of miR-155 levels. Our investigation revealed that miR-155 expression segregates with specific molecular subgroups of DLBCL and it is highest in activated B-cell (ABC)-type lymphomas. These tumors are characterized by constitutive activation of NF-κB signals, which supports the data derived from our cell lines. More importantly, using supervised learning algorithms, we identified a robust gene signature driven by the differential expression of miR-155. These profiles contained several gene markers, including predicted targets, consistently downregulated in tumors expressing high levels of miR-155. Our data start to unveil the genome-wide effects of miR-155 expression in DLBCL and indicate the utility of this strategy in the identification and validation of miRNA target genes.

AB - MicroRNAs (miRNAs) attenuate gene expression by pairing to the 3′UTR of target transcripts inducing RNA cleavage or translational inhibition. Overexpression of microRNA-155 (miR-155), measured either at the primary (BIC gene) or mature transcript level, was recently described in diffuse large B-cell lymphomas (DLBCL). These studies have been limited in size, however, and have not attempted to link miR-155 expression to that of putative target genes. To start to address these issues, we examined a collection of 22 well-characterized DLBCL cell lines. The expression of miR-155 is heterogeneous in these cell lines and associates with NF-κB activity. We found that the expression of the primary miR-155 transcript reliably reflects that of the functional mature miR-155. Because many gene array platforms include probe sets for the primary miR-155 sequences, these findings allowed us to confidently examine large array-based expression datasets of primary DLBCLs in the context of miR-155 levels. Our investigation revealed that miR-155 expression segregates with specific molecular subgroups of DLBCL and it is highest in activated B-cell (ABC)-type lymphomas. These tumors are characterized by constitutive activation of NF-κB signals, which supports the data derived from our cell lines. More importantly, using supervised learning algorithms, we identified a robust gene signature driven by the differential expression of miR-155. These profiles contained several gene markers, including predicted targets, consistently downregulated in tumors expressing high levels of miR-155. Our data start to unveil the genome-wide effects of miR-155 expression in DLBCL and indicate the utility of this strategy in the identification and validation of miRNA target genes.

UR - http://www.scopus.com/inward/record.url?scp=38849198550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849198550&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2007.10.008

DO - 10.1016/j.cancergencyto.2007.10.008

M3 - Article

C2 - 18262046

AN - SCOPUS:38849198550

VL - 181

SP - 8

EP - 15

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -